8-K 1 f71896e8-k.txt 8-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): APRIL 25, 2001 CARDIAC PATHWAYS CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) DELAWARE 000-28372 77-0278793 (STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)

995 BENECIA AVENUE SUNNYVALE, CA 94085 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (408) 737-0505 (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) 2 ITEM 5. OTHER EVENTS On April 25, 2001, Cardiac Pathways Corporation issued a press release which (i) announces Cardiac Pathway's results for its fiscal third quarter ended March 31, 2001 and (ii) describes compliance issues with respect to the continued listing of Cardiac Pathways' common stock on the Nasdaq National Market. The press release is attached as Exhibit 99.1 to this Form 8-K. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits.

3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARDIAC PATHWAYS CORPORATION (Registrant) Date: April 25, 2001 By: /s/ Thomas M. Prescott ------------------------------------- Thomas M. Prescott President and Chief Executive Officer -2- 4 EXHIBIT INDEX

-3-

CARDIAC PATHWAYS CORP 8-K